JOURNEY MED CORP holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 930,603 | $5,490,558 | 0.03% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 15, 2025 |
| June 30, 2025 | 1,152,059 | $8,271,784 | 0.04% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 14, 2025 |
| Sept. 30, 2025 | 1,306,272 | $9,300,657 | 0.05% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 14, 2025 |
| Dec. 31, 2025 | 1,316,275 | $10,148,480 | 0.06% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 12, 2026 |
| March 31, 2026 | 2,133,370 | $10,005,505 | 0.07% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | April 21, 2026 |
| June 30, 2026 | 2,858,930 | $20,241,224 | 0.13% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | July 10, 2026 |
| Sept. 30, 2026 | 2,449,253 | $16,752,891 | 0.12% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Oct. 13, 2026 |
7 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
Journey Medical Corp · SC 13G/A · Event June 30, 2026 · Filed July 15, 2026
| Reporting person | Reported shares | % of security class | Group box |
|---|---|---|---|
| Wasatch Advisors LP | 2,858,930.00 | 13.3% | a |
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.